HIV 1 News and Research

RSS

Global public health security in the 21st century

More than at any previous time in history, global public health security depends on international cooperation and the willingness of all countries to act effectively in tackling new and emerging threats.

23 Aug 2007

WHO says more killer diseases like AIDS on their way

The World Health Organisation (WHO) has warned the world to expect a new killer disease to emerge in the next few years which will threaten the lives of millions.

23 Aug 2007

South African experts say food no substitute for medical drugs in AIDS and TB

A report by the Academy of Science of South Africa has stated that there is no evidence to support the theory that a healthy diet is a substitute for medical drugs when it comes to treating HIV/AIDS and tuberculosis (TB).

22 Aug 2007

HIV denial in the Internet era

The Internet is serving as a fertile medium for "HIV denialists" to spread false ideas about HIV/AIDS, which could have terrible public health consequences, say scientists in a policy paper in PLoS Medicine.

22 Aug 2007

Premier forum on AIDS focuses on vaccine against HIV

An international conference on AIDS has gathered together over 900 global researchers, clinicians and specialists for the 2007 AIDS Vaccine Conference in Seattle.

21 Aug 2007

AIDS Vaccine Advocacy Coalition receives $14 million from Gates Foundation

The AIDS Vaccine Advocacy Coalition (AVAC) announced today at the AIDS Vaccine 2007 Conference that it has received a five-year, $14 million grant from the Bill & Melinda Gates Foundation to create a new international HIV Prevention Research Advocacy Network.

21 Aug 2007

Pharmion and MethylGene announce orphan drug designation for treatment of Hodgkin's lymphoma

Pharmion Corporation, along with its collaborator MethylGene Inc., today announced that the U.S. Food and Drug Administration (FDA) has designated the Companies' histone deacetylase (HDAC) inhibitor, MGCD0103, as an Orphan Drug for the treatment of Hodgkin's lymphoma in the United States.

21 Aug 2007

Tumors use enzyme to recruit regulatory T-cells and suppress immune response

One way tumors fly under the radar of the immune system is by using IDO, an enzyme used by fetuses to help avoid rejection, to recruit powerful regulatory T cells that turn down the immune response, researchers say.

17 Aug 2007

HIV protein both causes brain injury and prevents its repair

New evidence reported in the August issue of Cell Stem Cell, a publication of Cell Press, offers a novel perspective on how the HIV/AIDS virus leads to learning and memory deficits, a condition known as HIV-associated dementia.

17 Aug 2007

Scientists discover how HIV/AIDS disrupts the normal replication of stem cells in the adult brain

A prominent problem in AIDS is a form of dementia that robs one's ability to concentrate and perform normal movements.

17 Aug 2007

Immune deficiency linked to squamous cell eye cancer

The incidence of squamous cell eye cancer is greater among kidney transplant patients and people with human immunodeficiency virus (HIV) than the general public, which suggests the disease is associated with immune deficiency.

16 Aug 2007

Risk of bacterial vaginosis linked to preterm birth appears higher for African-Americans

Risk of a common vaginal infection linked to preterm birth appears to escalate when even one partner is African-American, according to a University of Pittsburgh School of Medicine study presented today at the 34th annual meeting of the Infectious Diseases Society for Obstetrics and Gynecology in Boston.

13 Aug 2007

FDA warns against use of red yeast rice products promoted as high cholesterol treatment

The U.S. Food and Drug Administration is warning consumers not to buy or eat three red yeast rice products promoted and sold on Web sites.

12 Aug 2007

Even older women at high risk have little interest in being tested for HIV

Few older women were interested in being tested for the virus that causes AIDS despite having significant risk factors for lifetime exposure, according to a study published in the July/August edition of the Journal of Women's Health.

8 Aug 2007

India rejects Novartis' drug patent claim

AIDS Healthcare Foundation (AHF), which operates free AIDS treatment clinics in India (Mysore, New Delhi and in Guwahati, Assam in collaboration with the National AIDS Control Organization) has applauded the news that an Indian court rejected a legal challenge mounted by the Swiss pharmaceutical company Novartis to a portion of India's Patent Act that restricts certain kinds of patents, a ruling that will protect access to affordable medicines in the developing world.

7 Aug 2007

FDA approves maraviroc, an antiretroviral drug for use in adult HIV patients.

The U.S. Food and Drug Administration (FDA) has approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.

7 Aug 2007

Abstinence only sex programmes - a waste of government money?

The latest research confirms and supports earlier work which has stated that programmes which exclusively advocate abstinence from sex in order to stop risky sexual behaviour or help in the prevention of unwanted pregnancy, are ineffective.

6 Aug 2007

Medic to sue Gaddafi for holding him hostage

One of the six medics imprisoned by Libyan authorities for allegedly deliberately infecting hundreds of Libyan children with HIV, plans to sue Libyan leader Colonel Gaddafi.

6 Aug 2007

Medical residents unclear about TB guidelines

US medical residents are not proficient at diagnosing and managing tuberculosis (TB), according to a report published in the online open access journal, BMC Infectious Diseases.

3 Aug 2007

Medical residents score poorly in diagnosing and managing tuberculosis

When quizzed about their knowledge in diagnosing tuberculosis and deciding on the best treatment, medical residents in Baltimore and Philadelphia get almost half the answers wrong, according to a survey by TB disease experts at Johns Hopkins and elsewhere.

3 Aug 2007